CVRx, Inc.
CVRX · XNASCIK 1235912fmd_09KCNB2D9VH0AHRSFR0RT0BK0KManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 26 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 6 | 13 | 22 | 39 | 51 | 57 |
| Cost of revenue | 1 | 4 | 5 | 6 | 8 | 8 |
| Gross profit | 5 | 9 | 17 | 33 | 43 | 48 |
| Research and development | 6 | 8 | 10 | 12 | 11 | 11 |
| Selling, general and administrative | 10 | 28 | 50 | 65 | 91 | 88 |
| Total operating expenses | 16 | 35 | 60 | 76 | 102 | 100 |
| Operating income | (12) | (26) | (43) | (43) | (59) | (51) |
| Interest expense | 2 | 2 | 0 | 2 | 4 | 6 |
| Other non-operating income (expense) | (0) | (15) | 1 | 4 | 4 | 4 |
| Income before taxes | (14) | (43) | (41) | (41) | (60) | (53) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | (0) |
| Net income from continuing operations | (14) | (43) | (41) | (41) | (60) | (53) |
| Net income | (14) | (43) | (41) | (41) | (60) | (53) |
| Net income to common shareholders | (14) | (43) | – | – | – | – |